Back to Results
First PageMeta Content
Vemurafenib / Metastasis / Protein kinase inhibitor / Cancer / Raf kinase / Skin cancer / Ipilimumab / Medicine / Melanoma / BRAF


1207: Final Decision Analytical Protocol (DAP) to guide the assessment of BRAF V600 mutation testing in patients with locally advanced or metastatic melanoma for eligibility for dabrafenib treatment
Add to Reading List

Document Date: 2014-11-06 23:50:12


Open Document

File Size: 1.022,85 KB

Share Result on Facebook
UPDATE